Dyne Therapeutics (DYN) Return on Assets (2020 - 2026)

Dyne Therapeutics (DYN) recorded quarterly Return on Assets of 0.0% in Q1 2026, up 9.14% quarter-over-quarter from 0.0% in Q4 2025, and little changed on a YoY basis from 0.0% in Q1 2025.

Dyne Therapeutics (DYN) Return on Assets (2020 - 2026) Analysis & Trends

Dyne Therapeutics' Return on Assets history runs 7 years deep, the most recent figure standing at 0.0% for Q1 2026.

  • In Q1 2026, Return on Assets changed 0.0% year-over-year to 0.0%; the TTM figure through Mar 2026 stood at 0.0% (changed 0.0% YoY), while the FY2025 annual figure was 0.0%, changed 0.0% from the prior year.
  • Return on Assets was 0.0% for Q1 2026 at Dyne Therapeutics, up from 0.0% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.0% in Q3 2024 to a low of 0.01% in Q4 2023.
  • Historically, Return on Assets has averaged 0.01% across 5 years, with a median of 0.01% in 2025.
  • The sharpest annual moves came in 2023 and 2024: Return on Assets slipped 1 bps in 2023, then gained 1 bps in 2024.
  • A 5-year view of Return on Assets shows it stood at 0.01% in 2022, then tumbled by 128 bps to 0.01% in 2023, then jumped by 66 bps to 0.0% in 2024, then grew by 1 bps to 0.0% in 2025, then rose by 9 bps to 0.0% in 2026.
  • The last three Return on Assets figures came in at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.01% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -0.80%
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -0.01%
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 0.00%
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -0.01%
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - 0.00%
7 Psyence Biomedical 251.43 Bn 251.42 Bn - 0.00%
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 0.00%
9 Abivax 94.37 Bn 94.37 Bn - -0.01%
10 Dyne Therapeutics 2.78 Bn 2.78 Bn - 0.00%

Historic Data

Download Data
DateValue
Mar 31, 2026 0.00%
Dec 31, 2025 0.00%
Sep 30, 2025 -0.01%
Jun 30, 2025 -0.01%
Mar 31, 2025 -0.01%
Dec 31, 2024 0.00%
Sep 30, 2024 0.00%
Jun 30, 2024 0.00%
Mar 31, 2024 -0.01%
Dec 31, 2023 -0.01%
Sep 30, 2023 -0.01%
Jun 30, 2023 -0.01%
Mar 31, 2023 -0.01%
Dec 31, 2022 -0.01%
Sep 30, 2022 -0.01%
Jun 30, 2022 -0.01%
Mar 31, 2022 0.00%
Dec 31, 2021 0.00%
Sep 30, 2021 0.00%
Jun 30, 2021 0.00%